ArticleCurrent infectious disease reports2015
Managing CAP in the ICU.
Article in Current infectious disease reports, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 4 citations in OpenAlex.
- Biomarker Value in the Diagnosis of Community-Acquired Pneumonia with Concomitant Chronic Heart Failure.Journal of clinical medicine · 2021Article
- [Infections in critically ill patients].Medicine · 2018Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Despite remarkable progress in diagnosis and antibiotic therapy, mortality due to pneumonia has not changed significantly and ICU admissions are increasing. The management includes early evaluation of severity, collection of microbiological cultures, and appropriate antibiotic administration. The prognostic scores as the ATS/IDSA rule, the PIRO, or SCAP system are valuable in timely recognition of critically ill patients with community-acquired pneumonia (CAP) requiring admission to ICU. Implementation of guidelines for CAP treatment should be emphasized in order to increase survival. Guidelines for antibiotic management for severe CAP are based on illness severity, covering most likely bacterial and atypical pathogens and the level of ICU antibiotic resistance. Combination therapy suggested in patients with nonrefractory septic shock and severe sepsis pneumococcal bacteremia also. Recent studies suggest that steroid therapy may be valuable in nonrefractory septic shock from sCAP.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.